Compare · BFLY vs PHG
BFLY vs PHG
Side-by-side comparison of Butterfly Network Inc. (BFLY) and Koninklijke Philips N.V. NY Registry Shares (PHG): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BFLY and PHG operate in Medical Electronics (Health Care), so they compete in similar markets.
- PHG is the larger of the two at $26.96B, about 11.2x BFLY ($2.41B).
- BFLY has been more active in the news (14 items in the past 4 weeks vs 4 for PHG).
- PHG has more recent analyst coverage (23 ratings vs 8 for BFLY).
- Company
- Butterfly Network Inc.
- Koninklijke Philips N.V. NY Registry Shares
- Price
- $9.04+1.06%
- $27.42-0.40%
- Market cap
- $2.41B
- $26.96B
- 1M return
- -
- +9.64%
- 1Y return
- -
- -1.37%
- Industry
- Medical Electronics
- Medical Electronics
- Exchange
- NYSE
- NYSE
- IPO
- 2020
- News (4w)
- 14
- 4
- Recent ratings
- 8
- 23
Butterfly Network Inc.
Butterfly Network, Inc., a digital health company, develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; and Butterfly iQ+, a point-of-care ultrasound imaging device that connects with a smart phone or tablet. The company serves healthcare practitioners. Butterfly Network, Inc. was incorporated in 2011 and is headquartered in Guilford, Connecticut.
Koninklijke Philips N.V. NY Registry Shares
Koninklijke Philips N.V. operates as a health technology company in North America, Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides magnetic resonance imaging, computed tomography, advanced molecular imaging, diagnostic X-ray, and imaging components as well as integrated clinical solutions; integrated interventional systems, including interventional diagnostic and therapeutic devices; imaging products focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. The company also offers monitoring and analytics solutions; sleep and respiratory care solutions; emergency care and resuscitation, and patient management solutions; data, analytics, and actionable workflow solutions; and connected care informatics solutions. In addition, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; male grooming and beauty products and solutions; and kitchen appliances, home care, and garment care products, as well as coffee machines. Koninklijke Philips N.V. has a partnership with openDoctor to deliver an integrated radiology patient engagement platform that leverages openDoctor's real-time online appointment scheduling services as part of its patient management solution; and a strategic collaboration with Ibex Medical Analytics Ltd. to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Latest BFLY
- President & CEO Devivo Joseph gifted 250,000 shares, decreasing direct ownership by 3% to 7,353,700 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13D/A filed by Butterfly Network Inc.
- Director Robbins Larry sold $20,622,493 worth of shares (2,297,733 units at $8.98) (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13D/A filed by Butterfly Network Inc.
- Director Phanstiel S. Louise bought $999,510 worth of shares (115,200 units at $8.68) (SEC Form 4)
- SEC Form SCHEDULE 13G filed by Butterfly Network Inc.
- Deputy General Counsel Caezza Nicholas sold $97,500 worth of shares (10,000 units at $9.75), decreasing direct ownership by 3% to 300,307 units (SEC Form 4)
- President & CEO Devivo Joseph sold $684,075 worth of shares (68,346 units at $10.01) as part of a pre-agreed trading plan, decreasing direct ownership by 0.89% to 7,603,700 units (SEC Form 4)
- Butterfly Network Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- SEC Form 144 filed by Butterfly Network Inc.
Latest PHG
- Philips prices EU green bond for EUR 650M
- Exor and Philips Extend Long-term Relationship Agreement
- Philips expands open patient monitoring ecosystem to help health systems keep sight of patients beyond the bedside
- Philips downgraded by UBS
- SEC Form 6-K filed by Koninklijke Philips N.V. NY Registry Shares
- Philips delivers solid comparable sales growth and margin in Q2; reiterates full year comparable sales growth outlook; Adjusted EBITA and free cash flow outlook increased to reflect US tariff refund
- Philips receives FDA 510(k) clearance for next-generation reusable SpO₂ clip sensor
- Philips introduces Alturion ultrasound system with AI-powered workflows for high-volume clinical environments
- Philips Sonicare Sets New Benchmark in Oral Healthcare with Brand's First Electric Toothbrush Powered By On-Device AI and Real-Time Spatially Aware Guidance, Helping People Brush with Greater Coverage And Confidence
- University Health in San Antonio selects Philips enterprise monitoring platform to transform patient monitoring and advance system-wide standardization as patient volume grows